143 related articles for article (PubMed ID: 9092246)
1. [A system of individual immunotherapy with leakadin in the combined therapy of acoustic neurinomas].
Starchenko AA; Khil'ko VA; Komarets SA; Khlunovskiĭ AN; Prilukova TI; Kraskovskaia SV; Danilov AV
Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):15-8. PubMed ID: 9092246
[TBL] [Abstract][Full Text] [Related]
2. [Leakadin immunotherapy in the combined therapy of acoustic neurinomas].
Starchenko AA; Khil'ko VA; Komarets SA; Khlunovskiĭ AN
Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(4):40-2. PubMed ID: 7856375
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy with leakadin in the combined therapy of acoustic neurinomas].
Khil'ko VA; Lantsov AA; Gorokhov AA; Starchenko AA; Komarets SA; Khlunovskiĭ AN
Vestn Otorinolaringol; 1994; (2):17-9. PubMed ID: 7855992
[TBL] [Abstract][Full Text] [Related]
4. [Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
Kikot' VA; Dziubko NIa
Vrach Delo; 1989 Jul; (7):46-8. PubMed ID: 2800496
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine].
Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA
Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769
[TBL] [Abstract][Full Text] [Related]
6. [The effect of vilozen on the immune status of bronchial asthma patients].
Kogosova LS; Kovalenko NN; Strafun OV; Markov AE
Vrach Delo; 1990 Oct; (10):48-50. PubMed ID: 2080579
[TBL] [Abstract][Full Text] [Related]
7. [A system of individual immunotherapy for intracranial complications and the local immune reactions of the cerebrospinal fluid].
Khil'ko VA; Starchenko AA; Khlunovskiĭ AN; Komarets SA; Prilukova TI; Vlasenko IE; Lushnov MS
Vestn Khir Im I I Grek; 1994; 153(7-12):60-2. PubMed ID: 7625039
[TBL] [Abstract][Full Text] [Related]
8. [Biological effects of leakadin].
Garin AM; Lichinitser MR; Dmitrieva NV; Rubtsov BI; Leneva NV
Vopr Onkol; 1988; 34(2):192-6. PubMed ID: 2964757
[TBL] [Abstract][Full Text] [Related]
9. [Immunoactive drugs in the combined modality therapy of patients with hypothyroidism].
Epishin AV; Grytsiv VE; Venger EP
Ter Arkh; 1991; 63(2):88-92. PubMed ID: 2048033
[TBL] [Abstract][Full Text] [Related]
10. [Role of hormones and mediators in the functioning of the immune system].
Petrov RV
Vestn Akad Med Nauk SSSR; 1980; (8):3-11. PubMed ID: 6106331
[No Abstract] [Full Text] [Related]
11. [Disorders of immune system function and their correction in melanomas with regional metastases].
Labunets IF; Grinevich IuA; Tolstopiatov BA
Vopr Onkol; 1989; 35(4):416-23. PubMed ID: 2728381
[TBL] [Abstract][Full Text] [Related]
12. [Immunocorrective therapy of pyelonephritis in children].
Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
Marconi P; Bistoni F
Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
[No Abstract] [Full Text] [Related]
15. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
16. [The immunomodulating action of bestatin in the combined therapy of bladder cancer patients].
Neprina GS; Panteleeva ES; Vatin OE; Kariakin OB
Urol Nefrol (Mosk); 1994; (2):34-8. PubMed ID: 8017004
[TBL] [Abstract][Full Text] [Related]
17. [Galvanization of the area of the spleen as a method of immunocorrection in patients with chronic bronchitis].
Siurin SA
Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (4):21-3. PubMed ID: 9424824
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation in vitro. The predictive value of in vitro testing of lung cancer patients' lymphocyte responsiveness to stimulation by Thymex L. A preliminary report.
Vucković-Dekić L; Stanojević-Bakić N; Rajner L; Dekić M; Pesić M
J Exp Clin Cancer Res; 1997 Sep; 16(3):309-12. PubMed ID: 9387906
[TBL] [Abstract][Full Text] [Related]
19. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
20. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
